Genmab at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Genmab takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on partnering and business development, from dealmaking in a shifting global landscape to the next chapter for European biotech. One, shared with Ropes & Gray, traces the path from partnering pioneer to global biotech company.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Genmab Copenhagen, Denmark | |
Danish biotech developing antibody therapeutics for cancer and other diseases. | Panel Mon Nov 9 13:00–14:00 Navigating partnering and business development in a shifting global landscape How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples. Panel Tue Nov 10 10:45–11:15 From Partnering Pioneer to Global Biotech Leader: The Next Chapter for European Innovation How Genmab grew from licensing its discoveries to others into a global company selling its own drugs, and what European biotechs can learn. |
Instantly find 20 buyers from Genmab
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction